The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Maria Domenica Cappellini

Università di Milano

Policlinico Foundation IRCCS

Milan

Italy

[email]@unimi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Università di Milano, Policlinico Foundation IRCCS, Milan, Italy. 2009 - 2010
  • Policlinico, Mangiagalli, Regina Elena Foundation IRCCS, University of Milan, Italy. 1998 - 2010
  • Department of Internal Medicine, University of Milan, Policlinico, Mangiagalli, Italy. 2005 - 2008
  • Fondazione Policlinico, Pad. Granelli, Via F. Sforza 35, 20122 Milano, Italy. 2007
  • Centre for Congenital Anaemias and Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre and Department of Internal Medicine, IRCCS Maggiore Hospital and University of Milan, Italy. 2000
  • Hereditary Anaemia Centre, Ospedale Maggiore IRCCS, Department of Internal Medicine, University of Milano Medical School, Italy. 1999

References

  1. Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Cappellini, M.D., Porter, J., El-Beshlawy, A., Li, C.K., Seymour, J.F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J.W., Chan, L.L., Lin, K.H., Rose, C., Taher, A., Thein, S.L., Viprakasit, V., Habr, D., Domokos, G., Roubert, B., Kattamis, A. Haematologica (2010) [Pubmed]
  2. Oral iron chelators. Cappellini, M.D., Pattoneri, P. Annu. Rev. Med. (2009) [Pubmed]
  3. Overview of iron chelation therapy with desferrioxamine and deferiprone. Cappellini, M.D., Musallam, K.M., Taher, A.T. Hemoglobin (2009) [Pubmed]
  4. Insight onto the pathophysiology and clinical complications of thalassemia intermedia. Cappellini, M.D., Musallam, K.M., Taher, A.T. Hemoglobin (2009) [Pubmed]
  5. Long-term efficacy and safety of deferasirox. Cappellini, M.D. Blood Rev. (2008) [Pubmed]
  6. Current status in iron chelation in hemoglobinopathies. Cappellini, M.D., Piga, A. Curr. Mol. Med. (2008) [Pubmed]
  7. Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload. Cappellini, M.D., Taher, A. Expert. Opin. Pharmacother (2008) [Pubmed]
  8. Glucose-6-phosphate dehydrogenase deficiency. Cappellini, M.D., Fiorelli, G. Lancet (2008) [Pubmed]
  9. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Cappellini, M.D., Bejaoui, M., Agaoglu, L., Porter, J., Coates, T., Jeng, M., Lai, M.E., Mangiagli, A., Strauss, G., Girot, R., Watman, N., Ferster, A., Loggetto, S., Abish, S., Cario, H., Zoumbos, N., Vichinsky, E., Opitz, H., Ressayre-Djaffer, C., Abetz, L., Rofail, D., Baladi, J.F. Clin. Ther (2007) [Pubmed]
  10. Coagulation in the pathophysiology of hemolytic anemias. Cappellini, M.D. Hematology. Am. Soc. Hematol. Educ. Program (2007) [Pubmed]
  11. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Cappellini, M.D., Cohen, A., Piga, A., Bejaoui, M., Perrotta, S., Agaoglu, L., Aydinok, Y., Kattamis, A., Kilinc, Y., Porter, J., Capra, M., Galanello, R., Fattoum, S., Drelichman, G., Magnano, C., Verissimo, M., Athanassiou-Metaxa, M., Giardina, P., Kourakli-Symeonidis, A., Janka-Schaub, G., Coates, T., Vermylen, C., Olivieri, N., Thuret, I., Opitz, H., Ressayre-Djaffer, C., Marks, P., Alberti, D. Blood (2006) [Pubmed]
  12. Iron-chelating therapy with the new oral agent ICL670 (Exjade). Cappellini, M.D. Best. Pract. Res. Clin. Haematol (2005) [Pubmed]
  13. Overcoming the challenge of patient compliance with iron chelation therapy. Cappellini, M.D. Semin. Hematol. (2005) [Pubmed]
  14. Coagulation and splenectomy: an overview. Cappellini, M.D., Grespi, E., Cassinerio, E., Bignamini, D., Fiorelli, G. Ann. N. Y. Acad. Sci. (2005) [Pubmed]
  15. Hematologically important mutations: acute intermittent porphyria. Cappellini, M.D., Martinez di Montemuros, F., Di Pierro, E., Fiorelli, G. Blood Cells Mol. Dis. (2002) [Pubmed]
  16. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT). Cappellini, M.D., Martinez di Montemuros, F., Tavazzi, D., Fargion, S., Pizzuti, A., Comino, A., Cainelli, T., Fiorelli, G. Hum. Mutat. (2001) [Pubmed]
  17. Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia. Domenica Cappellini, M., Tavazzi, D., Duca, L., Marelli, S., Fiorelli, G. Transfus. Sci (2000) [Pubmed]
  18. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Cappellini, M.D., Robbiolo, L., Bottasso, B.M., Coppola, R., Fiorelli, G., Mannucci, A.P. Br. J. Haematol. (2000) [Pubmed]
  19. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia. Cappellini, M.D., Tavazzi, D., Duca, L., Graziadei, G., Mannu, F., Turrini, F., Arese, P., Fiorelli, G. Br. J. Haematol. (1999) [Pubmed]
  20. Butyrate trials. Cappellini, M.D., Graziadei, G., Ciceri, L., Comino, A., Bianchi, P., Pomati, M., Fiorelli, G. Ann. N. Y. Acad. Sci. (1998) [Pubmed]
 
WikiGenes - Universities